These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 17564487)
1. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. Hill PC; Brookes RH; Fox A; Jackson-Sillah D; Jeffries DJ; Lugos MD; Donkor SA; Adetifa IM; de Jong BC; Aiken AM; Adegbola RA; McAdam KP PLoS Med; 2007 Jun; 4(6):e192. PubMed ID: 17564487 [TBL] [Abstract][Full Text] [Related]
2. Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. Hill PC; Jeffries DJ; Brookes RH; Fox A; Jackson-Sillah D; Lugos MD; Donkor SA; de Jong BC; Corrah T; Adegbola RA; McAdam KP PLoS One; 2007 Jan; 2(1):e183. PubMed ID: 17264885 [TBL] [Abstract][Full Text] [Related]
3. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. Adetifa IM; Lugos MD; Hammond A; Jeffries D; Donkor S; Adegbola RA; Hill PC BMC Infect Dis; 2007 Oct; 7():122. PubMed ID: 17961228 [TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Winthrop KL; Nyendak M; Calvet H; Oh P; Lo M; Swarbrick G; Johnson C; Lewinsohn DA; Lewinsohn DM; Mazurek GH Clin J Am Soc Nephrol; 2008 Sep; 3(5):1357-63. PubMed ID: 18550653 [TBL] [Abstract][Full Text] [Related]
5. Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection. Mantegani P; Piana F; Codecasa L; Galli L; Scarpellini P; Lazzarin A; Cirillo D; Fortis C Clin Med Res; 2006 Dec; 4(4):266-72. PubMed ID: 17210976 [TBL] [Abstract][Full Text] [Related]
6. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. Lawn SD; Bangani N; Vogt M; Bekker LG; Badri M; Ntobongwana M; Dockrell HM; Wilkinson RJ; Wood R BMC Infect Dis; 2007 Aug; 7():99. PubMed ID: 17725839 [TBL] [Abstract][Full Text] [Related]
7. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Ewer K; Millington KA; Deeks JJ; Alvarez L; Bryant G; Lalvani A Am J Respir Crit Care Med; 2006 Oct; 174(7):831-9. PubMed ID: 16799072 [TBL] [Abstract][Full Text] [Related]
8. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection. Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583 [TBL] [Abstract][Full Text] [Related]
9. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? Pai M; O'Brien R PLoS Med; 2007 Jun; 4(6):e208. PubMed ID: 17564491 [TBL] [Abstract][Full Text] [Related]
10. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Hill PC; Fox A; Jeffries DJ; Jackson-Sillah D; Lugos MD; Owiafe PK; Donkor SA; Hammond AS; Corrah T; Adegbola RA; McAdam KP; Brookes RH Clin Infect Dis; 2005 Jan; 40(2):273-8. PubMed ID: 15655747 [TBL] [Abstract][Full Text] [Related]
11. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Diel R; Ernst M; Döscher G; Visuri-Karbe L; Greinert U; Niemann S; Nienhaus A; Lange C Eur Respir J; 2006 Jul; 28(1):16-23. PubMed ID: 16481383 [TBL] [Abstract][Full Text] [Related]
12. Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting. Buchwald UK; Adetifa IM; Bottomley C; Owiafe PK; Donkor S; Bojang AL; Sutherland JS PLoS One; 2014; 9(12):e116268. PubMed ID: 25549338 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940 [TBL] [Abstract][Full Text] [Related]
14. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. Aiken AM; Hill PC; Fox A; McAdam KP; Jackson-Sillah D; Lugos MD; Donkor SA; Adegbola RA; Brookes RH BMC Infect Dis; 2006 Mar; 6():66. PubMed ID: 16573826 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793 [TBL] [Abstract][Full Text] [Related]
16. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Hill PC; Brookes RH; Adetifa IM; Fox A; Jackson-Sillah D; Lugos MD; Donkor SA; Marshall RJ; Howie SR; Corrah T; Jeffries DJ; Adegbola RA; McAdam KP Pediatrics; 2006 May; 117(5):1542-8. PubMed ID: 16651307 [TBL] [Abstract][Full Text] [Related]
18. Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia. Hill PC; Brookes RH; Fox A; Jackson-Sillah D; Lugos MD; Jeffries DJ; Donkor SA; Adegbola RA; McAdam KP PLoS One; 2006 Dec; 1(1):e68. PubMed ID: 17183699 [TBL] [Abstract][Full Text] [Related]